0
Skip to Content
Context Therapeutics
About
Pipeline
Patients
Careers
Investors & News
Context Therapeutics
About
Pipeline
Patients
Careers
Investors & News
About
Pipeline
Patients
Careers
Investors & News
Poster 2625 - Identification of CTX-30916 as a new antagonist of progesterone receptor signaling pathways
Poster Martin Lehr 4/1/19 Poster Martin Lehr 4/1/19

Poster 2625 - Identification of CTX-30916 as a new antagonist of progesterone receptor signaling pathways

2019 AACR Annual Meeting

Read More
Poster 926 - Onapristone enhances the anti-proliferative effects of CDK4/6 inhibitors in preclinical in-vitro breast cancer models
Poster Martin Lehr 12/4/18 Poster Martin Lehr 12/4/18

Poster 926 - Onapristone enhances the anti-proliferative effects of CDK4/6 inhibitors in preclinical in-vitro breast cancer models

2018 San Antonio Breast Cancer Symposium

Read More

About Us
Leadership
Partnering
Contact Us

Pipeline
CTIM-76
CT-95
CT-202

Patients
Clinical Trials
Investigator Led Trials
Access Policy

Investors & Media
News

Careers
Open Positions

Privacy Policy          Terms of Use

© Context Therapeutics Inc. 2025  |  All Rights Reserved